Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID.
Neurology
; 67(7): 1275-8, 2006 Oct 10.
Article
em En
| MEDLINE
| ID: mdl-17030766
ABSTRACT
The WASID trial showed no advantage of warfarin over aspirin for preventing the primary endpoint of ischemic stroke, brain hemorrhage, or vascular death. In analyses of selected subgroups, there was no definite benefit from warfarin. Warfarin reduced the risk of the primary endpoint among patients with basilar artery stenosis, but there was no reduction in stroke in the basilar artery territory or benefit for vertebral artery stenosis or posterior circulation disease in general.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Varfarina
/
Doenças Arteriais Cerebrais
/
Aspirina
/
Medição de Risco
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Limite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Neurology
Ano de publicação:
2006
Tipo de documento:
Article
País de afiliação:
Estados Unidos